Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvation Regulatory News (AVAP)

Share Price Information for Avation (AVAP)

Share Price is delayed by 15 minutes
Get Live Data
133.50    -1.50 (-1.11%)
Bid:
133.50
Ask:
134.50
Spread: 1.00 (0.749%)
Market Cap: £79.99m
AVAP Live PriceLast checked at - London Stock Exchange

Intraday Avation Share Chart

EQUITY ISSUE ON WARRANT EXERCISE DIRECTORS DEALING

11 Mar 2025 09:05

RNS Number : 1888A
Avation PLC
11 March 2025
 

 Via RNS and SGXNET

AVATION PLC

("Avation" or "the Company")

EQUITY ISSUE ON WARRANT EXERCISE AND DIRECTORS' DEALING

The Board of Avation PLC (LSE: AVAP), announces that on 11 March 2025, the Company allotted 278,371 fully paid new ordinary shares representing approximately 0.37 per cent of the enlarged capital of the Company pursuant to the exercise of staff share warrants as well as the exercise of the Company's listed warrants (LSE:AVAW).

Pursuant to the exercise of staff warrants as set out below, the Company allotted 264,867 fully paid new ordinary shares representing approximately 0.35 per cent of the enlarged capital of the Company:

- 216,867 series 2022 warrants at an exercise price of 102 pence per share

- 38,000 series 2023 warrants at an exercise price of 126 pence per share

- 5,000 series 2023 warrants at an exercise price of 125.5 pence per share

- 5,000 series 2024 warrants at an exercise price of 118 pence per share

Pursuant to the exercise of 13,504 listed warrants, the Company allotted a further 13,504 fully paid new ordinary shares representing approximately 0.02 per cent of the enlarged capital of the Company. The listed warrants have an exercise price of 114.5 pence per share.

The exercise of the staff and listed warrants provides the Company with £296,721.42 in proceeds which the Company will use for general corporate purposes.

The allotments of shares are conditional only on admission of the new shares to the Official List and to trading on the London Stock Exchange's main market for listed securities becoming effective ("Admission"). Application will be made for the new ordinary shares to be listed on the Official List of the UK Listing Authority and to be admitted to trading on the London Stock Exchange's main market for listed securities. It is expected that Admission will become effective and that dealings in the new ordinary shares will commence on or around 19 March 2025.

The new ordinary shares will, when issued, rank pari passu in all respects with the existing ordinary shares including the right to receive dividends and other distributions declared Following Admission.

Following Admission, there will be a total of 74,950,257 ordinary shares in issue, with 8,130,000 shares held in treasury. Following Admission there will be 66,820,257 total voting rights for the purpose of calculating shareholders' percentage voting rights.

DIRECTORS' DEALING

Robert Jeffries Chatfield, a director, subscribed (via a company in which he is interested) for 100,999 ordinary shares as part of this allotment. In addition to this subscription, Mr Chatfield has advised the Company that the beneficial ownership of 50,000 ordinary shares in the Company has passed to him for nil consideration under the terms of a trust. Accordingly, his direct and indirect holdings in ordinary shares will be 12,381,000 on Admission becoming effective, which represents 18.53 per cent of the voting rights and 16.52 per cent of the enlarged share capital.

-ENDS-

Enquiries:

Avation PLC - Jeff Chatfield, Executive Chairman +65 6252 2077

Avation welcomes shareholder questions and comments and advises the email address for questions is: investor@avation.net and the Company provides an investor Q & A during the conference call associated with release of results. The head office telephone number is +65 62522077.

Notes to Editors: Avation PLC is an aircraft leasing company, headquartered in Singapore, owning and managing a fleet of commercial passenger aircraft which it leases to airlines around the world. More information on Avation is available at www.avation.net.

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCAs") with them.

 

1.

Details of the PDMR / person closely associated

a)

Name

Robert Jeffries Chatfield

2.

Reason for the notification

a)

Position / status

Executive Chairman

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Avation PLC

b)

LEI

213800KA972GUP1B6I78

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.01 each

GB00B196F554 (ISIN)

b)

Nature of the transaction

Exercise of warrants to subscribe for ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£1.02

100,999

 

d)

Aggregated information

See above

- Aggregated volume

- Price

e)

Date of the transaction

11 March 2025

f)

Place of the transaction

London Stock Exchange

 

1.

Details of the PDMR / person closely associated

a)

Name

Robert Jeffries Chatfield

2.

Reason for the notification

a)

Position / status

Executive Chairman

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Avation PLC

b)

LEI

213800KA972GUP1B6I78

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.01 each

GB00B196F554 (ISIN)

b)

Nature of the transaction

Transfer of beneficial ownership pursuant to the terms of a trust

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£NIL

50,000

 

d)

Aggregated information

See above

- Aggregated volume

- Price

e)

Date of the transaction

11 March 2025

f)

Place of the transaction

NA

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUARKRVAUOARR
Date   Source Headline
23rd Dec 20257:58 amRNSAVAW WARRANTS EXERCISE
27th Nov 20257:00 amRNSDirectorate change
26th Nov 202510:14 amRNSResult of AGM
26th Nov 202510:10 amRNSWARRANT GRANT AND DIRECTORS’ DEALING
26th Nov 20257:00 amRNSAGM Statement
24th Nov 20253:32 pmRNSANNUAL REPORT ON NATIONAL STORAGE MECHANISM
21st Nov 202512:23 pmRNSAGM TELECONFERENCE
21st Nov 202512:23 pmRNSWARRANT EXERCISE AND DIRECTORS’ DEALING
11th Nov 20259:22 amRNSREDEMPTION OF SENIOR NOTES DUE 2026
11th Nov 20257:59 amRNSCREDIT RATING – S&P
7th Nov 20257:08 amRNSAVAW WARRANTS – ORDERLY EXERCISE PROCESS
7th Nov 20257:03 amRNSNOTES REPURCHASE POLICY UPDATE
6th Nov 20257:00 amRNSHolding(s) in Company
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20258:42 amRNSCREDIT RATING
4th Nov 20257:00 amRNSNotice of AGM
4th Nov 20257:00 amRNSHolding(s) in Company
30th Oct 20257:10 amRNSTRANSACTION IN OWN SHARES AND TOTAL VOTING RIGHTS
29th Oct 20257:31 amRNSWIDEBODY LEASE EXTENSION
23rd Oct 20255:51 pmRNSHolding(s) in Company
23rd Oct 20255:10 pmRNSUS$300 MILLION SENIOR UNSECURED NOTES
22nd Oct 20254:10 pmRNSDIVIDEND CURRENCY EXCHANGE RATE
21st Oct 20251:57 pmRNSNEW BOND ISSUE – GMTN PROGRAMME
21st Oct 20251:54 pmRNSESTABLISHMENT OF NEW US$1B GMTN PROGRAMME
21st Oct 20257:00 amRNSHolding(s) in Company
15th Oct 20257:00 amRNSDIVIDEND CURRENCY AND ELECTION
13th Oct 20257:00 amRNSNEW AIRLINE LEASE AGREEMENT
8th Oct 20257:00 amRNSHolding(s) in Company
6th Oct 20257:00 amRNSMANDATE ANNOUNCEMENT
3rd Oct 20253:18 pmRNSTRANSACTION IN OWN SHARES AND TOTAL VOTING RIGHTS
2nd Oct 20257:00 amRNSPUBLICATION OF AUDITED FINANCIAL STATEMENTS
2nd Oct 20257:00 amRNSDividend Declaration
2nd Oct 20257:00 amRNSAnnual Financial Report
26th Sep 20251:32 pmRNSFINANCIAL YEAR 2025 RESULTS AND INVESTOR CALL
12th Sep 202510:46 amRNSADMISSION OF NEW ORDINARY SHARES
12th Sep 202510:42 amRNSHolding(s) in Company
11th Sep 202511:00 amRNSHolding(s) in Company
9th Sep 202510:45 amRNSSALE COMPLETION OF BOEING 777 AIRCRAFT
8th Sep 20257:00 amRNSTRADING UPDATE AND RESULTS TIMING
4th Sep 202510:53 amRNSISSUE OF EQUITY
4th Sep 202510:46 amRNSWARRANT GRANT AND DIRECTORS’ DEALING
4th Sep 202510:07 amRNSNEW ATR LEASE AGREEMENT SIGNED
3rd Sep 20259:08 amRNSNEW LEASE AGREEMENT SIGNED
31st Jul 20257:00 amRNSCREDIT RATING
22nd Jul 20259:25 amRNSUPDATE GLOBAL MEDIUM TERM NOTE PROGRAMME
21st Jul 20257:00 amRNSCOMPLETION OF AIRCRAFT TRANSITION
9th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20258:17 amRNSDirector/PDMR Shareholding
4th Jul 20257:04 amRNSTrading Statement
4th Jul 20257:00 amRNSTreasury Stock

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.